The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Praill Scott since year 2005.
The trader's CIK number is 1332948.
At the time of this reporting, Praill Scott is the Chief Financial Officer of Delmar Pharmaceuticals, Inc. .
(stock ticker symbol DMPI).
See this page for all insider trading activities at Delmar Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-05||DMPI||Delmar Pharmaceuticals, Inc.||Buy||17,500||.85||14,910|
|2017-06-26||DMPI||Delmar Pharmaceuticals, Inc.||Buy||4,167||3.60||15,001|
|2017-06-06||DMPI||Delmar Pharmaceuticals, Inc.||Buy||9,500||2.10||19,950|
|2015-07-16||DMPI||Delmar Pharmaceuticals, Inc.||Buy||50,000||.60||30,000|
|2014-03-18||DMPI||Delmar Pharmaceuticals, Inc.||Buy||10,000||1.30||13,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Praill Scott (Chief Financial Officer of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.